Realm Therapeutics PLC Company Profile (LON:PURI)

About Realm Therapeutics PLC (LON:PURI)

Realm Therapeutics PLC logoRealm Therapeutics plc, formerly PuriCore plc, is a biopharmaceutical company. The Company is focused on leveraging its immunomodulatory technology to protect and improve the health of adults and children. The Company has initiated drug development programs based on its hypochlorous acid technology. The Company is engaged in the development of small molecule therapies with potential application for the treatment of diseases in a number of therapeutic areas, and an initial focus in dermatology and ophthalmology. The Company has developed proprietary formulations of its technology, with anti-inflammatory and immunomodulatory benefits. Its pipeline of products include PR013 and PR022, which are in Phase I. PR013 is indicated for allergic conjunctivitis and PR022 is indicated for atopic dermatitis. Realm Therapeutics, Inc. is a subsidiary of the Company.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: N/A
  • Symbol: LON:PURI
  • CUSIP: N/A
  • Web: www.realmtx.com
Average Prices:
  • 52 Week Range: GBX 16.90 - GBX 31.40
P/E:
  • Trailing P/E Ratio:
  • P/E Growth:
Profitability:
  • Net Margins: -902.53%
  • Return on Equity: -49.39%
  • Return on Assets: -41.39%
Misc:
  • Average Volume: 32,220 shs.
 

Frequently Asked Questions for Realm Therapeutics PLC (LON:PURI)

What is Realm Therapeutics PLC's stock symbol?

Realm Therapeutics PLC trades on the London Stock Exchange (LON) under the ticker symbol "PURI."

When will Realm Therapeutics PLC make its next earnings announcement?

Realm Therapeutics PLC is scheduled to release their next quarterly earnings announcement on Monday, September, 18th 2017. View Earnings Estimates for Realm Therapeutics PLC.

Who are some of Realm Therapeutics PLC's key competitors?

Who are Realm Therapeutics PLC's key executives?

Realm Therapeutics PLC's management team includes the folowing people:

  • John Alex Martin, Chief Executive Officer, Executive Director
  • Marella Thorell, Chief Financial Officer, Finance Director, Chief Operating Officer, Executive Director, Company Secretary
  • Charles A. E. Spicer, Non-Executive Chairman
  • Ivan Philip Gergel M.D., Non-Executive Director
  • Balkrishan Gill, Non-Executive Director of the Board
  • Matthew C. P. Hammond, Non-Executive Director
  • Daniel Hegglin, Non-Executive Director

How do I buy Realm Therapeutics PLC stock?

Shares of Realm Therapeutics PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Realm Therapeutics PLC's stock price today?

One share of Realm Therapeutics PLC stock can currently be purchased for approximately GBX 28.75.


MarketBeat Community Rating for Realm Therapeutics PLC (LON PURI)
Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  21
MarketBeat's community ratings are surveys of what our community members think about Realm Therapeutics PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Realm Therapeutics PLC (LON:PURI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Realm Therapeutics PLC (LON:PURI)
Show:
DateFirmActionRatingPrice TargetDetails
9/20/2016N+1 SingerReiterated RatingCorporateView Rating Details
(Data available from 8/23/2015 forward)

Earnings

Earnings History for Realm Therapeutics PLC (LON:PURI)
Earnings by Quarter for Realm Therapeutics PLC (LON:PURI)
Earnings History by Quarter for Realm Therapeutics PLC (LON PURI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/18/2017N/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Realm Therapeutics PLC (LON:PURI)
Current Year EPS Consensus Estimate: $0.09 EPS

Dividends

Dividend History for Realm Therapeutics PLC (LON:PURI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Realm Therapeutics PLC (LON:PURI)
Insider Trades by Quarter for Realm Therapeutics PLC (LON:PURI)
Insider Trades by Quarter for Realm Therapeutics PLC (LON:PURI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2016Charles SpicerInsiderBuy17,482GBX 29£5,069.78
3/29/2016Martin,AlexInsiderBuy100,000GBX 28£28,000
10/14/2015Hegglin ,DanielInsiderBuy500,000GBX 18£90,000
9/28/2015Spicer,CharlesInsiderBuy77,922GBX 19£14,805.18
4/1/2015Charles SpicerInsiderBuy50,610GBX 32£16,195.20
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Realm Therapeutics PLC (LON:PURI)
Latest Headlines for Realm Therapeutics PLC (LON:PURI)
Source:

Social

Social activity is not available for this stock.

Chart

Realm Therapeutics PLC (PURI) Chart for Wednesday, August, 23, 2017

This page was last updated on 8/23/2017 by MarketBeat.com Staff